Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among patients with diabetes. As such, healthcare professionals must be equipped with strategies to assess and mitigate cardiovascular risk in this population.
Cardiovascular risk assessment should be a routine part of diabetes management. The American Diabetes Association recommends using a validated tool, such as the UKPDS risk engine, which considers factors like age, sex, ethnicity, smoking status, and HbA1c levels. It is also essential to monitor for symptoms of CVD and carry out regular blood pressure, lipid profile, and renal function tests.
Hyperglycemia is a significant risk factor for CVD. Therefore, achieving and maintaining glycemic control is crucial. Individualized HbA1c targets should be set, and a combination of lifestyle modification and pharmacotherapy should be used to achieve these targets. Drugs like metformin, GLP-1 receptor agonists, and SGLT2 inhibitors have shown cardiovascular benefits in addition to their glucose-lowering effects.
Besides hyperglycemia, other risk factors like hypertension, dyslipidemia, and obesity should also be addressed. Hypertension should be managed with lifestyle changes and antihypertensive medications, aiming for a target blood pressure of <130/80 mmHg. Dyslipidemia should be treated with statins, and in some cases, ezetimibe or PCSK9 inhibitors. Weight management strategies, including dietary changes, physical activity, and sometimes bariatric surgery, should be implemented for overweight or obese patients.
Managing cardiovascular risk in diabetic patients requires a comprehensive, multifaceted approach that involves regular risk assessment, glycemic control, and management of other cardiovascular risk factors. By adopting these strategies, healthcare professionals can significantly improve the cardiovascular health and overall prognosis of their diabetic patients.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation